Targos

Kassel, Germany Founded: 2005 • Age: 21 yrs Acquired By Discovery Life Sciences
Biomarkers are developed and analyzed for clinical trials by Targos.

About Targos

Targos is a company based in Kassel (Germany) founded in 2005 by Thomas Henkel was acquired by Discovery Life Sciences in May 2021.. Targos operates in a competitive market with competitors including Evelo Biosciences, PathogenDX, BioAgilytix, Advion and Omass, among others.

  • Headquarter Kassel, Germany
  • Founders Thomas Henkel
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Services & Infrastructure
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Targos

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Targos

Targos has secured backing from 1 investor. Prominent investors backing the company include Discovery Life Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Provider of diversified services with integrated technology platforms for drug discovery
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Targos

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Targos

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Targos Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Targos

Targos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evelo Biosciences, PathogenDX, BioAgilytix, Advion and Omass, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
domain founded_year HQ Location
Provider of DNA-based pathogen testing kits
domain founded_year HQ Location
Large-molecule bioanalysis is provided for biologics and biosimilars development.
domain founded_year HQ Location
Microfluidics and mass spectrometry products are provided for clinical research.
domain founded_year HQ Location
Native mass spectrometry services for protein characterization are provided.
domain founded_year HQ Location
Analytical and quality assurance services are provided for diverse industries.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Targos

When was Targos founded?

Targos was founded in 2005.

Where is Targos located?

Targos is headquartered in Kassel, Germany. It is registered at Kassel, Hesse, Germany.

Who is the current CEO of Targos?

Thomas Henkel is the current CEO of Targos. They have also founded this company.

What does Targos do?

Targos is an FDA-inspected, GCP-compliant, CAP accredited, CLIA-enrolled central laboratory offering biomarker analysis and biomarker development services mainly for clinical trials. They claim to have analysed samples of more than 60,000 patients, in100 clinical trials pertaining to breast, gastric, lung and skin cancers in more than 1000 sites worldwide, since their inception. The company has a biomarker service portfolio catering to 44 biomarkers. Their laboratories are capable of analysing biomarkers through a portfolio of techniques including IHC, ISH, mutation analysis, parallel sequencing, ELISA andor digital pathology and others. The company has board certified pathologists who coordinate clinical trials. Targos also offers clinical trial services such as project, data and quality management and logistics. The company also offer services for the development of companion diagnostics (CDx) and had supported the first development of CDx for Roche COBAS and B-RAF along with the GenentechRoche drug Zelboraf in a prospective clinical trial.

Who are the top competitors of Targos?

Targos's top competitors include PathogenDX, Alderley Analytical and BioAgilytix.

Who are Targos's investors?

Targos has 1 investor. Key investors include Discovery Life Sciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available